Clarius Group LLC’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Hold |
6,092
| – | – | 0.01% | 420 |
|
|
2025
Q1 | $236K | Buy |
+6,092
| New | +$236K | 0.01% | 419 |
|
|
2024
Q3 | – | Sell |
-5,514
| Closed | -$212K | – | 463 |
|
|
2024
Q2 | $212K | Sell |
5,514
-1,997
| -27% | -$76.9K | 0.02% | 405 |
|
|
2024
Q1 | $322K | Sell |
7,511
-429
| -5% | -$18.4K | 0.02% | 316 |
|
|
2023
Q4 | $294K | Buy |
7,940
+68
| +0.9% | +$2.52K | 0.02% | 357 |
|
|
2023
Q3 | $285K | Sell |
7,872
-561
| -7% | -$20.3K | 0.03% | 347 |
|
|
2023
Q2 | $301K | Buy |
8,433
+732
| +10% | +$26.1K | 0.02% | 390 |
|
|
2023
Q1 | $274K | Sell |
7,701
-2,831
| -27% | -$101K | 0.02% | 408 |
|
|
2022
Q4 | $370K | Buy |
+10,532
| New | +$370K | 0.03% | 320 |
|
|
2022
Q3 | – | Sell |
-5,015
| Closed | -$273K | – | 506 |
|
|
2022
Q2 | $273K | Buy |
5,015
+268
| +6% | +$14.6K | 0.03% | 361 |
|
|
2022
Q1 | $262K | Hold |
4,747
| – | – | 0.02% | 400 |
|
|
2021
Q4 | $262K | Buy |
+4,747
| New | +$262K | 0.02% | 400 |
|
|
2020
Q3 | – | Sell |
-4,026
| Closed | -$205K | – | 309 |
|
|
2020
Q2 | $205K | Sell |
4,026
-587
| -13% | -$29.9K | 0.03% | 266 |
|
|
2020
Q1 | $218K | Sell |
4,613
-510
| -10% | -$24.1K | 0.04% | 228 |
|
|
2019
Q4 | $305K | Sell |
5,123
-7
| -0.1% | -$417 | 0.05% | 199 |
|
|
2019
Q3 | $274K | Buy |
5,130
+658
| +15% | +$35.1K | 0.05% | 207 |
|
|
2019
Q2 | $224K | Buy |
+4,472
| New | +$224K | 0.05% | 224 |
|